Effectivity and safety profile of tenapanor, a sodium-hydrogen exchanger isoform 3 inhibitor, as an innovative treatment for hyperphosphatemia in chronic kidney disease: A systematic review of clinical studies William Suciangto; Haerani Rasyid; Anastasya Angelica Vicente; Winny Suciangto;

Cardiovascular and renal outcomes according across to KDIGO stages of chronic kidney disease in the Spanish population: insights from real-world evidence Rafael Santamaria; Carlos Escobar; Unai Aranda; Beatriz Palacios; Margarita Capel; Ignacio Hernández; Ana Cebrián; Roberto Alcázar; Manuel Gorostidi;

The multiple functions of Insulin-like Growth Factor 1 in kidney disease Juan Miguel Diaz Tocados; Aurora Pérez Gómez; Juan Diego Domínguez Coral; José Manuel Valdivielso;